US BANCORP \DE\ - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$992
-12.9%
2,5500.0%0.00%
Q2 2023$1,139
-71.3%
2,550
-47.2%
0.00%
Q1 2023$3,962
-48.7%
4,832
-2.3%
0.00%
Q4 2022$7,719
-48.5%
4,948
-44.0%
0.00%
Q3 2022$15,000
+50.0%
8,831
+52.6%
0.00%
Q2 2022$10,000
-64.3%
5,787
-24.1%
0.00%
Q1 2022$28,000
-22.2%
7,623
+5.3%
0.00%
Q4 2021$36,000
-35.7%
7,240
-7.8%
0.00%
Q3 2021$56,000
-40.4%
7,856
-22.4%
0.00%
Q2 2021$94,000
+17.5%
10,130
+18.1%
0.00%
Q1 2021$80,000
+29.0%
8,576
+21.9%
0.00%
Q4 2020$62,000
-18.4%
7,036
+7.4%
0.00%
Q3 2020$76,000
-53.9%
6,549
+6.7%
0.00%
Q2 2020$165,000
+230.0%
6,139
-8.1%
0.00%
Q1 2020$50,000
+1566.7%
6,683
+568.3%
0.00%
Q4 2019$3,000
+50.0%
1,0000.0%0.00%
Q3 2019$2,000
-33.3%
1,0000.0%0.00%
Q2 2019$3,000
-25.0%
1,0000.0%0.00%
Q1 2019$4,0000.0%1,0000.0%0.00%
Q4 2018$4,000
-33.3%
1,0000.0%0.00%
Q3 2018$6,000
+50.0%
1,0000.0%0.00%
Q2 2018$4,000
-20.0%
1,0000.0%0.00%
Q1 2018$5,000
+25.0%
1,0000.0%0.00%
Q4 2017$4,000
-33.3%
1,0000.0%0.00%
Q3 2017$6,000
-25.0%
1,0000.0%0.00%
Q2 2017$8,000
+14.3%
1,0000.0%0.00%
Q1 2017$7,0000.0%1,0000.0%0.00%
Q4 2016$7,000
-22.2%
1,0000.0%0.00%
Q3 2016$9,0000.0%1,0000.0%0.00%
Q2 2016$9,0001,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders